A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
EDGEWELL PERSONAL CARE Co
EPC
$1.3B
Mkt Cap
$27.63
+3.52%
EDGEWELL PERSONAL CARE Co (EPC) has a 5-year average return on invested capital (ROIC) of 6.0%. This is below average and may indicate limited pricing power.
EDGEWELL PERSONAL CARE Co (EPC) has a market capitalization of $1.3B. It is classified as a small-cap stock.
Yes, EDGEWELL PERSONAL CARE Co (EPC) pays a dividend with a trailing twelve-month yield of 2.25%. The company also returns capital through share buybacks, with a buyback yield of 3.17%.
EDGEWELL PERSONAL CARE Co (EPC) operates in the Perfumes, Cosmetics & Other Toilet Preparations industry, within the Consumer Defensive sector.
EDGEWELL PERSONAL CARE Co (EPC) reported annual revenue of $2.2 billion in its most recent fiscal year, based on SEC EDGAR filings.
EDGEWELL PERSONAL CARE Co (EPC) has a net profit margin of 1.1%. This is a modest margin.
EDGEWELL PERSONAL CARE Co (EPC) generated $41 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
(in millions, except per share data) Edgewell Personal Care Company, and its subsidiaries, is one of the world’s largest manufacturers and marketers of personal care products in the Wet Shave, Sun and Skin Care, and Feminine Care segments. With operations in approximately 20 countries, our products are widely available in more than 50 countries. History and Development We were incorporated in the State of Missouri on September 23, 1999 and, prior to April 2000, were a wholly-owned subsidiary of Ralston Purina Company. On April 1, 2000, all of the outstanding shares of our common stock were distributed to shareholders of Ralston Purina Company and we became an independent publicly-owned company. During the years that followed, we implemented a strategy of acquiring several personal care brands, which created the foundation for the company we are today. In 2003, we completed the acquisition of the Schick-Wilkinson Sword business (“SWS”) from Pfizer, Inc.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.1B | 2.2B | 2.3B | 2.3B | 2.2B | 2.1B |
| Net Income | -78M | 25M | 99M | 115M | 100M | 118M |
| EPS | $-1.67 | $0.53 | $1.97 | $2.21 | $1.85 | $2.13 |
| Free Cash Flow | 49M | 41M | -288M | -266M | 46M | 172M |
| ROIC | 0.6% | 3.6% | 6.1% | 6.6% | 5.6% | 8.0% |
| Gross Margin | 40.6% | 41.6% | 42.4% | 41.8% | 40.5% | 45.6% |
| Debt/Equity | 0.86 | 0.89 | 0.80 | 0.88 | 0.95 | 0.78 |
| Dividends/Share | $0.62 | $0.61 | $0.61 | $0.61 | $0.61 | $0.46 |
| Operating Income | 17M | 97M | 199M | 227M | 182M | 240M |
| Operating Margin | 0.8% | 4.3% | 8.8% | 10.1% | 8.4% | 11.5% |
| ROE | -5.4% | 1.6% | 6.3% | 7.6% | 6.5% | 7.8% |
| Shares Outstanding | 46M | 48M | 50M | 52M | 54M | 55M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 2.6B | 2.4B | 2.4B | 2.3B | 2.2B | 2.1B | 1.9B | 2.1B | 2.2B | 2.3B | 2.3B | 2.2B | 2.1B |
| Gross Margin | 49.4% | 48.9% | 49.1% | 49.0% | 46.2% | 45.1% | 45.2% | 45.6% | 40.5% | 41.8% | 42.4% | 41.6% | 40.6% |
| R&D | 70M | 71M | 72M | 68M | 61M | 54M | 55M | 58M | 56M | 59M | 58M | 58M | 59M |
| SG&A | 535M | 572M | 413M | N/A | N/A | 723M | 705M | 711M | 698M | 410M | 430M | 425M | 430M |
| EBIT | 593M | -338M | 292M | 16M | 232M | 244M | 176M | 240M | 182M | 227M | 199M | 97M | 17M |
| Op. Margin | 22.7% | -14.0% | 12.3% | 0.7% | 10.4% | 11.4% | 9.0% | 11.5% | 8.4% | 10.1% | 8.8% | 4.3% | 0.8% |
| Net Income | 356M | -275M | 179M | 5.7M | 103M | -372M | 68M | 118M | 100M | 115M | 99M | 25M | -78M |
| Net Margin | 13.6% | -11.4% | 7.6% | 0.2% | 4.6% | -17.4% | 3.5% | 5.6% | 4.6% | 5.1% | 4.4% | 1.1% | -3.7% |
| Non-Recurring | 50M | -6.0M | 37M | 33M | 75M | 453M | 22M | 20M | 14M | 14M | 35M | 97M | 64M |
| Returns on Capital | |||||||||||||
| ROIC | 17.9% | -7.7% | 9.6% | 0.6% | 5.3% | 10.2% | 6.2% | 8.0% | 5.6% | 6.6% | 6.1% | 3.6% | 0.6% |
| ROE | 14.1% | -14.8% | 9.8% | 0.3% | 5.9% | -24.4% | 4.9% | 7.8% | 6.5% | 7.6% | 6.3% | 1.6% | -5.4% |
| ROA | 5.1% | -5.5% | 3.7% | 0.1% | 2.5% | -10.1% | 1.9% | 3.3% | 2.7% | 3.1% | 2.6% | 0.7% | -2.2% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 572M | 149M | 176M | 314M | 259M | 191M | 233M | 229M | 102M | -216M | -231M | 118M | 117M |
| Free Cash Flow | 487M | 49M | 107M | 245M | 197M | 133M | 185M | 172M | 46M | -266M | -288M | 41M | 49M |
| Owner Earnings | 405M | 600K | 58M | 197M | 145M | 79M | 125M | 115M | -12M | -335M | -346M | 5.1M | 10M |
| CapEx | 85M | 99M | 70M | 69M | 62M | 58M | 48M | 57M | 56M | 50M | 57M | 77M | 69M |
| Maint. CapEx | 136M | 115M | 93M | 94M | 98M | 94M | 89M | 87M | 90M | 91M | 88M | 89M | 86M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 136M | 115M | 93M | 94M | 98M | 94M | 89M | 87M | 90M | 91M | 88M | 89M | 86M |
| CapEx/OCF | 14.9% | 66.8% | 37.2% | 22.0% | 23.9% | 30.4% | 20.5% | 24.8% | 55.3% | N/A | N/A | 65.0% | 58.6% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 124M | 93M | 0 | 0 | 0 | 0 | 0 | 26M | 33M | 32M | 31M | 29M | 29M |
| Dividend Yield | 2.0% | 1.7% | N/A | N/A | N/A | N/A | N/A | 1.3% | 1.7% | 1.6% | 1.7% | 2.1% | 2.2% |
| Share Buybacks | 94M | 175M | 197M | 165M | 124M | 0 | 0 | 9.2M | 125M | 75M | 59M | 90M | 40M |
| Buyback Yield | 1.8% | 4.0% | 4.7% | 4.4% | 5.4% | N/A | N/A | 0.5% | 6.6% | 4.1% | 3.3% | 9.6% | 3.2% |
| Stock-Based Comp | 31M | 33M | 26M | 22M | 17M | 18M | 19M | 27M | 24M | 28M | 27M | 25M | 21M |
| Debt Repayment | 140M | 1.9B | 631M | 568M | 788M | 324M | 167M | 0 | 552M | 874M | 901M | 825M | 825M |
| Balance Sheet | |||||||||||||
| Net Debt | -29M | 274M | 630M | 1.0B | 1.0B | 873M | 873M | 925M | 1.2B | 1.1B | 1.1B | 1.2B | 949M |
| Cash & Equiv. | 1.1B | 712M | 739M | 503M | 266M | 342M | 365M | 309M | 189M | 216M | 209M | 226M | 300M |
| Long-Term Debt | 1.8B | 1.7B | 1.5B | 1.5B | 1.1B | 1.1B | 1.2B | 1.2B | 1.4B | 1.4B | 1.3B | 1.4B | 1.2B |
| Debt/Equity | 0.88 | 0.91 | 1.15 | 0.88 | 0.74 | 0.93 | 0.86 | 0.78 | 0.95 | 0.88 | 0.80 | 0.89 | 0.86 |
| Interest Coverage | 5.0 | -3.4 | 4.1 | 0.2 | 3.4 | 3.9 | 2.9 | 3.5 | 2.6 | 2.9 | 2.6 | 1.3 | 0.2 |
| Equity | 2.5B | 1.9B | 1.8B | 1.7B | 1.7B | 1.3B | 1.4B | 1.6B | 1.5B | 1.5B | 1.6B | 1.6B | 1.4B |
| Total Assets | 6.9B | 5.0B | 4.8B | 4.2B | 4.0B | 3.4B | 3.5B | 3.7B | 3.7B | 3.7B | 3.7B | 3.8B | 3.5B |
| Total Liabilities | 4.4B | 3.1B | 2.9B | 2.4B | 2.2B | 2.1B | 2.1B | 2.1B | 2.2B | 2.2B | 2.1B | 2.2B | 2.1B |
| Intangibles | 1.8B | 1.4B | 1.4B | 1.1B | 1.1B | 913M | 928M | 906M | 997M | 974M | 949M | 921M | 813M |
| Retained Earnings | 1.4B | 773M | 946M | 953M | 1.1B | 715M | 782M | 866M | 939M | 1.0B | 1.1B | 1.1B | 996M |
| Working Capital | 1.2B | 970M | 584M | 662M | 234M | 385M | 473M | 599M | 403M | 439M | 372M | 430M | 496M |
| Current Assets | 2.7B | 1.6B | 1.5B | 1.2B | 951M | 1.0B | 984M | 1.1B | 942M | 962M | 936M | 996M | 1.1B |
| Current Liabilities | 1.6B | 667M | 868M | 524M | 717M | 660M | 510M | 537M | 540M | 523M | 564M | 566M | 614M |
| Per Share Data | |||||||||||||
| EPS | 4.22 | -4.44 | 2.99 | 0.10 | 1.90 | -6.88 | 1.24 | 2.13 | 1.85 | 2.21 | 1.97 | 0.53 | -1.67 |
| Owner EPS | 4.80 | 0.01 | 0.97 | 3.46 | 2.66 | 1.46 | 2.29 | 2.07 | -0.22 | -6.45 | -6.90 | 0.11 | 0.23 |
| Book Value | 29.88 | 30.06 | 30.60 | 30.56 | 32.09 | 24.09 | 26.39 | 28.76 | 27.28 | 29.68 | 31.65 | 32.41 | 31.43 |
| Cash Flow/Share | 6.78 | 2.40 | 2.95 | 5.50 | 4.77 | 3.52 | 4.27 | 4.14 | 1.90 | -4.16 | -4.62 | 2.47 | 0.17 |
| Dividends/Share | 1.47 | 1.50 | 1.50 | 0.00 | N/A | 0.00 | 0.00 | 0.46 | 0.61 | 0.61 | 0.61 | 0.61 | 0.62 |
| Shares Out. | 84.4M | 62.0M | 59.8M | 57.0M | 54.4M | 54.1M | 54.5M | 55.3M | 53.8M | 51.9M | 50.1M | 47.9M | 46.1M |
| Valuation | |||||||||||||
| P/E Ratio | 14.5 | N/A | 23.4 | 661.3 | 22.2 | N/A | 20.4 | 16.3 | 19.0 | 16.1 | 18.0 | 36.9 | -16.6 |
| P/FCF | 14.3 | 89.7 | 39.2 | 15.4 | 11.6 | 12.0 | 7.5 | 11.2 | 41.4 | N/A | N/A | 22.7 | 26.2 |
| EV/EBIT | 12.0 | N/A | 18.1 | 275.4 | 14.3 | 10.1 | 12.8 | 11.9 | 16.9 | 13.2 | 14.4 | 22.0 | 131.5 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.1 | 0.6 | 0.9 |
| Price/Sales | 1.7 | 2.2 | 1.8 | 1.7 | 1.2 | 0.9 | 0.8 | 0.9 | 0.9 | 0.9 | 0.8 | 0.6 | 0.6 |
| FCF Yield | 9.4% | 1.1% | 2.6% | 6.5% | 8.6% | 8.3% | 13.4% | 9.0% | 2.4% | -14.4% | -16.2% | 4.4% | 3.8% |
| Market Cap | 5.2B | 4.4B | 4.2B | 3.8B | 2.3B | 1.6B | 1.4B | 1.9B | 1.9B | 1.8B | 1.8B | 938M | 1.3B |
| Avg. Price | 71.62 | 87.05 | 72.80 | 68.56 | 49.13 | 34.33 | 27.32 | 34.62 | 36.44 | 38.61 | 36.12 | 28.83 | 27.63 |
| Year-End Price | 82.37 | 71.50 | 70.10 | 66.13 | 42.16 | 29.48 | 25.33 | 34.72 | 35.09 | 35.51 | 35.42 | 19.57 | 27.63 |
EDGEWELL PERSONAL CARE Co passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 35.6x vs a median of 13.7x. The company's 5-year average ROIC is 6.0% with a gross margin of 42.4%. Total shareholder yield (dividends + buybacks) is 5.4%. At current prices, the estimated annualized return to fair value is -8.8%.
EDGEWELL PERSONAL CARE Co (EPC) has a debt-to-equity ratio of 0.89. This indicates moderate leverage.
EDGEWELL PERSONAL CARE Co (EPC) reported earnings per share (EPS) of $0.53 in its most recent fiscal year.
EDGEWELL PERSONAL CARE Co (EPC) has a return on equity (ROE) of 1.6%. This indicates moderate shareholder returns.
EDGEWELL PERSONAL CARE Co (EPC) has a 5-year average gross margin of 42.4%. This indicates decent pricing power.
The Ledger Terminal provides 18 years of financial data for EDGEWELL PERSONAL CARE Co (EPC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
EDGEWELL PERSONAL CARE Co (EPC) has a book value per share of $32.41, based on its most recent annual SEC filing.
No recent press releases.